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Accepted 16 July 2018; Published online 21 July 2018AbstractObjective: To develop guidance for authors of diagnostic test accuracy (DTA) reviews to help them write a plain language summary of
the results of their review.
Study Design and Setting: We used a combination of focus groups, user testing, and a web-based survey. Participants included patient
representatives, media representatives, and health professionals.
Results: We present step-by-step guidance for authors of DTA reviews for writing a plain language summary. This guidance is illus-
trated with examples of reader-tested sentences, explanations, and a figure.
Conclusion: We hope this guidance will allow reviewers to present the findings of DTA reviews so that it is easier for readers to un-
derstand the results and conclusions. This will increase the accessibility of these reviews for various audiences.  2018 The Authors.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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A plain language summary (PLS) is an easy-to-read
summary of a systematic review and should provide rapid
access to the content of the review [1]. Just like the abstract
of an article, PLSs are generally made freely available on
the internet, so will often be read as stand-alone documents.
A clear PLS is essential to ensure that systematic re-
views are accessible to users who are not familiar with
the more technical content of a review. Complexity of
methods and understanding of diagnostic accuracyConflicts of interest: None of the authors have any conflicts of interest
to declare.
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0895-4356/ 2018 The Authors. Published by Elsevier Inc. This is an open acc
licenses/by-nc-nd/4.0/).measures is likely to increase the diversity of the audience
for PLS for diagnostic research. Thus, users of a PLS may
not be limited to the public but may also include health care
professionals, policy makers, and the media.
Explaining the results of a diagnostic test accuracy
(DTA) review in plain language presents particular chal-
lenges. The review methodology and terminology are less
familiar than reviews of interventions [2]. Commonly used
measures of test accuracy such as sensitivity, specificity,
positive and negative predictive values, and likelihood ra-
tios are poorly understood by health professionals [3].
Research has shown that readers familiar with systematic
review methods have difficulties understanding DTA re-
views and that familiarity with intervention reviews may
even be a disadvantage [4]. DTA reviews are concerned
with evaluating test accuracy and do not directly evaluate
whether introduction of a new test will result in betteress article under the CC BY-NC-ND license (http://creativecommons.org/
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Key findings
 This paper introduces new guidance for reviewers
on how to write plain language summaries of diag-
nostic test accuracy reviews.
What this adds to what was known?
 Previous research has shown that understanding
and application of test accuracy evidence is
challenging.
What is the implication and what should change
now?
 Improving the accessibility of test accuracy evi-
dence has the potential to positively impact test
use.
 Authors of DTA reviews should use our proposed
guidance to present the results of their reviews to
make them easier for readers to understand.
outcomes for patients. The potential benefits of improved
test accuracy will only be realized if introduction of a
new test results in a change in diagnostic yield, in other
words, revision of a diagnosis leading to an appropriate
change in patient management [5].
Reporting test accuracy using natural frequencies and vi-
sual aids rather than using probabilistic language may facil-
itate improved understanding and better estimation of the
post-test probability of disease [3]. In addition, DTA re-
views are characterized by a large degree of heterogeneity
in results across studies, the reason for this variation is not
always clear and explaining this to users is difficult [4].
Sources of bias in DTA studies differ from those of inter-
vention studies, and implications of the impact of bias are
not always clearly understood [6].
Here, we present step-by-step guidance for authors of
DTA reviews for writing a PLS. This guidance is illustrated
with examples of reader-tested sentences, explanations, and
a figure.
P. Whiting et al. / Journal of CliniFig. 1. Outline of process used to develop PLS guidance.2. Methods
We prepared this guidance based on the findings of
research funded by the Cochrane Collaboration and draw-
ing on the PLS guidance for Cochrane Intervention Re-
views [1]. Although the template and guidance were
developed primarily for Cochrane DTA reviews, they are
equally relevant to any DTA review.
We used a mixed methods approach consisting of focus
groups, user testing, web-based surveys and a public
engagement event to develop this guidance (Fig. 1).Initial focus groups were conducted with a range of po-
tential end users: one with consumers (eight participants),
one with journalists (nine participants), and one with clini-
cians (two participants). During the focus groups, we pre-
sented two example PLS for discussiondan existing PLS
from a DTA review and a PLS that we rewrote based on
guidance on how to structure a PLS for a Cochrane Inter-
vention review [1], with some modifications to fit the tem-
plate to DTA reviews (PLS 0.1). Some minor corrections to
wording of the PLS were made following focus group 1
(PLS 0.2). We also included several alternative methods
for presenting the numerical results of the review. Partici-
pants were asked about their general views on the two
PLSs, what they liked and disliked about each, and how
the two compared. We then asked them about their views
on how numerical results should be presented and which
of the four alternative suggestions presented they preferred.
There was a clear preference for our new suggested struc-
ture, and to include a figure, there were also a number of
suggestions for improvements. Based on the results of the
focus group, we produced a revised PLS with substantial
changes to wording and headings and inclusion of a figure
to summarize numerical results [7]. This updated PLS (PLS
0.3) was used for the next stage of the development
processdone-on-one user testing with potential stake
holders: four clinicians, one journalist, one commissioner,
one review author, and one patient representative. All sup-
ported the changes made following the focus groups with
some additional changes suggested to the wording of some
sections.
Fig. 2. Template for developing test consequence graphic. (For interpretation of the references to color in this figure legend, the reader is referred to
the Web version of this article.)
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survey to gain feedback from a wider group of participants
on the same version of the PLS that was used for the user
testing (PLS 0.3). This was completed by 67 respondents
including media representatives, methodologists, systematic
review authors, health professionals, and patient representa-
tives. Therewas strong support for the proposed structure and
numerical presentation of results, although suggestions were
made to improve the wording of the PLS, including the title
and section headings. A refined version was produced (PLS
0.4) and was considered as part of the second round of theFig. 3. Test consequence graphic showing results that would be obtained if a
using rapid tests.survey. Minor wording changes were made to this after the
second round of the survey (PLS 0.5), and this version was
used for a public engagement event where we presented the
example PLS to a group of 16- to 18-year-old school students.
Further minor wording changes were suggested as well as
some changes to the figure tomake it easier to read. They also
suggested that it would be helpful to include a narrative sum-
mary of the numerical results in addition to the graphical
display. We modified the PLS to take this feedback into ac-
count and shared this version for further feedback during
workshops at Cochrane Colloquia (PLS 0.6). After this, wehypothetical cohort of 1000 children were tested for strep A infection
115P. Whiting et al. / Journal of Clinical Epidemiology 103 (2018) 112e119finalized the PLS (PLS 0.7) and produced a guidance docu-
ment to accompany it. This version together with the guid-
ance was piloted by a small number of reviewers and then
shared with Cochrane DTA Editors after further minor adap-
tations (PLS 0.8). All were positive about the PLS structure
and guidance with only minor changes needed to finalize
the guidance and example PLS included here.
Our research generated the following subheadings for
structuring a PLS. Belowwe provide a description of the con-
tent and suggested wording for each subheading, illustrated
using an example PLS for a systematic review of rapid tests
for diagnosing group A streptococcus infection in children
with sore throat [8]. The complete PLS for this review is pro-
vided as a web appendix (Web Appendix 1). An additional
complete PLS example based on a review of the IQCODE
questionnaire to diagnose dementia in hospital [9] is also pro-
vided as a web appendix (Web Appendix 2).Example: Why is improving the diagnosis of bac-
terial infection important?
Sore throat is very common in children. It can be
caused by viruses or bacteria. Antibiotic treatment is
only useful for sore throat caused by bacteria, which
is usually caused by group A streptococcus (‘‘strep
throat’’). Not recognizing bacterial infection when it
is present (a false negative test result) may result in de-
layed recovery and an increased risk of infecting
others. It may also result in rare but serious complica-
tions such as abscesses in the throat, bacterial infection
of the sinuses and ears, and rheumatic fever. An incor-
rect diagnosis of bacterial infection (a false positive
test result) may mean that children are given antibi-
otics when there is no benefit to be gained.2.1. Review title
If the review title is difficult to understand, for instance, if
it includes technical terms or jargon, consider rewriting it in
plain language. As a minimum, the review title should
contain information about the following three key elements:
The test or tests being studied (index tests). It is important to
ensure the type of test being studied is clear (e.g., question-
naire, a blood test, a swab, a urine test, or some formofmedical
imaging). For example, describing the index test as a ‘‘rapid’’
test with no further information does not convey the implica-
tions of having the test for an individual.
The condition that the test is designed to detect (the
target condition).
The people who will receive the test (e.g., adults, chil-
dren, people with certain symptoms such as sore throat or
low back pain). It may also be important to include any re-
strictions on the health care setting where the test will be
applied, for example, if the test will only be used in hospital
settings and not the community.Example: ‘‘How accurate are rapid swab tests for
strep throat in children?’’
Example: What is the aim of this review?
The aim of this review was to find out how accu-
rate rapid tests are for diagnosing bacterial infection
in children with sore throat. Researchers included
98 studies to answer this question.2.2. Why is improving [..] diagnosis important?
This subheading should include information about the
target condition and how use of the index test might benefit in-
dividuals suspected of having the target condition. For
example, the index test may be more accurate, may provide
quicker results, or may bemore accessible (less costly, require
less expertise) than tests currently in use.A brief description of
the downstream consequences of testing should be included. It
is helpful to introduce the concept of test errorsd‘‘false pos-
itive’’ and ‘‘false negative’’dat this early stage.Our research to develop this guidance demonstrated that
the downstream consequences of test errors were considered
particularly important by potential users. A sentence on the
benefits of making a correct diagnosisda true positive (in-
dex test positive and target condition present) and a true
negative (index test negative and target condition not pre-
sent) test resultsdis therefore helpful to include here.
 What are the consequences of a false positive result
(index test positive but target condition not present,
i.e., incorrectly labeling individuals as having the
condition when they do not)?
 What are the consequences of a false negative result
(index test negative but target condition present, i.e.,
missing the diagnosis of the condition in an individual
who has the condition)?2.3. What is the aim of this review?
The aim of the review should be stated as concisely and
simply as possible. Our research illustrated that users do not
always understand that the results of a PLS come from a
systematic review rather than a single study. Some also
wrongly assume that the review authors have carried out
the studies included in the review themselves. We therefore
suggest using an introductory sentence such as ‘‘The aim of
this review was to find out how accurate [..]. Researchers
included [X#] studies to answer this question.’’
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Give a brief description of the review topic considering
the following questions:
 What was the index test(s) addressed in the review?
Give enough information for readers to judge whether
the test(s) being studied is relevant to them, for
example, where in the clinical pathway is the test
likely to be applied?
 What is the role of the index test (e.g., triage, add-on, or
replacement test) [10]? Authors should avoid using
these technical terms and instead describe how the in-
dex test would be placed in the current testing pathway.
 If there is more than one index test included in a review
the PLS should also explain how these tests differ. For
example, one testmay bequicker to give results or easier
to perform, tests may be produced by a different manu-
facturer or require different processing techniques, one
test may be blood test and another, a swab test.
 Our research demonstrated that the presence of the
target condition may not be considered a ‘‘positive’’
outcome and so the term ‘‘positive’’ test result should
be avoided. Instead describe the test result that indi-
cates if the target condition is present.Example: What was studied in the review?
Two types of rapid tests were studied. These use
different biochemical methods to identify the bacterial
infection. Rapid tests require just a simple throat swab
from the patient. This gives an immediate result allow-
ing clinicians to decidewhether to prescribe antibiotics.
This is an advantage compared with conventional labo-
ratory tests that take 48 hours to give a result.2.5. What are the main results in this review?
2.5.1. Describing the included studies
In this section, the number of included studies and total
number of participants should briefly be described. To
clarify that the number of participants applies to the sum to-
tal of participants across included studies, it is helpful to
structure this sentence as follows:
‘‘The review included [x#] relevant studies with a total
of [x#] participants.’’
2.5.2. Presenting information on test accuracy
We suggest presenting the summary accuracy data using
natural frequencies based on a hypothetical cohort of 1000
patients [7].
Presentation of sensitivity and specificity are the most
commonly used metric in DTA reviews [11]. Tables 1
and 2 can be used to derive natural frequencies from sum-
mary sensitivities and specificities in a DTA review. Onlinetools are also available that will perform these calculations,
for example, GRADEPro [12].
The numbers to populate this table can be calculated by
taking summary estimates of sensitivity, specificity, and
prevalence (p) from the systematic review as follows
(Tables 1 and 2):
An estimate of the prevalence should be taken from the
systematic review, either the mean or median prevalence
across studies, unless there is a good rationale for taking
an alternative estimate.
2.5.3. Suggested text for presenting accuracy data
The results of these studies indicate that in theory, if the
[index test] were to be used in [setting] in a group of 1000
people where [x (p%)] have [target condition],
 an estimated [TP þ FP] would have an [index test]
result indicating [target condition] is present and of
these [FP] (!100*FP/{TP þ FP}O) would be incor-
rectly classified as having the [target condition];
 of the [TN þ FN] people with a result indicating that
[target condition] is not present, [FN] (!100*FN/
{TN þ FN}O%) would be incorrectly classified as
not having [target condition]
We propose a flow diagram to summarize these results
(Fig. 2). This can be populated from Tables 1 and 2 com-
bined with the information on implications that is described
in the subheading ‘‘Why is improving [..] diagnosis
important?’’
Note that in the formulas aforementioned and in the
figure template:
text in square brackets, [ ], is replaced with text or
numbers in the boxes in the final figure;
text in angle brackets,!O indicate expressions to be
calculated;
capitalized TP, FP, TN, and FN indicate variables to
be replaced with numbers;
lower case tp, fp, tn, and fn are shown unchanged in
the final figure.
We suggest only including one flow diagram to summa-
rize the main results to facilitate understanding. Variation in
accuracy for each index test from that presented in the flow
diagram (e.g., according to test threshold, quality of
studies, or differences in characteristics of the population
to be tested) can be included in the text.
If multiple summary estimates are available in the re-
view (e.g., more than one index test, different thresholds,
different population groups), the following issues need to
be considered when deciding which estimate to present as
the main results accompanied by a flow diagram. If there
are multiple tests, you may choose the test that has the po-
tential to have most impact on clinical practice (e.g., cost,
speed of result, invasiveness) or the most accurate test. If
multiple summary estimates of accuracy are presented for
a single test, you may select the estimate of accuracy
117P. Whiting et al. / Journal of Clinical Epidemiology 103 (2018) 112e119derived from the threshold that most studies contributed to,
the estimate considered most reliable (e.g., restricted to
studies at low risk of bias), or the estimate based on the
most relevant population (that most likely to be considered
for testing in clinical practice). The most appropriate
approach will vary across reviews and will require your
judgment and knowledge of the topic area.
If meta-analysis was not possible or appropriate in a
DTA review, then consider whether there are any data that
could be presented using the format described previously. If
this is not possible, a narrative description of results shouldExample: What are the main results of the review?
The analysis included results from 58,244 children
with sore throats. The results of these studies indicate
that in theory, if rapid tests were to be used in a group
of 1000 children with sore throats, of whom 300 (30%)
are actually caused by bacterial infection, then an esti-
mated 289 would have a rapid test result indicating
that their sore throat is caused by a bacterial infection
and of these, 32 (11%) would not have a bacterial
infection; and an estimated 711 children would have
a rapid test result indicating that their sore throat is
not caused by a bacterial infection and of these, 43
(6%) would actually have a bacterial infection (Fig. 3).
Example: How reliable are the results of the
studies in this review?
The numbers shown in the figure are averagesbe presented using natural frequencies.across all studies in the review. Because result esti-
mates from individual studies varied, we cannot be
sure that these rapid tests will always produce the
same results. In the included studies, the diagnosis
of bacterial infection was confirmed by the most ac-
curate test available: seeing if bacteria could be
grown in the laboratory from samples taken from
children’s throats. Although there were problems
with the conduct of some studies, their results did
not differ from the more reliable studies.2.6. How reliable are the results of the studies in this
review?
In this section, a summary of the quality of the studies
included in the review and the potential impact of bias on
estimates of accuracy is presented. The first sentence
should describe the reference standard used in the review.
A footnote may be used to explain that you are talking
about the reference standard for readers familiar with this
term, without causing potential confusion by including
the term in the text. A comment on whether the reference
standard is considered reliable may be helpful. For
example,‘‘In the included studies, the diagnosis of [target con-
dition] was made by assessing all patients with [refer-
ence standard]*.This is likely to have been a reliable
method for deciding whether patients really had
[target condition].’’‘‘*In these studies [reference standard] was the refer-
ence standard.’’If there was a potential for risk of bias in the included
studies, we suggest using a generic statement and thenexplaining how bias may have impacted on estimates of test
accuracy. We do not recommend going into detail about the
type of bias that may have affected the included studies
such as verification bias or review bias. For example,‘‘However, there were some problems with how the
studies were conducted. This may result in the [index
test] appearing more accurate than it really is,
increasing the number of correct [index test] results
(green rectangles) in the diagram.’’If there is substantial heterogeneity in study results, this
can be highlighted here. For example,‘‘The numbers shown in the figure are an average
across studies in the review. However as estimates
from individual studies included in the review varied
we cannot be sure that the [test] will always produce
these results.’’Lack of precision (wide confidence intervals around
summary estimates) and/or small sample size can also be
captured in this section. For example,‘‘Not enough people have been studied to be confi-
dent about the results.’’2.7. Who do the results of this review apply to?
This section should provide a brief summary of the
included studies. The mean or median prevalence and range
of the target condition across studies should be included.
This is particularly important if this is the estimate of the
prevalence that was used to populate the figure and to
calculate the frequencies for the results section. In addition,
a brief summary of pertinent characteristics of included
studies should be presented. Information that might be use-
ful includes the countries in which the studies were con-
ducted, details on baseline patient criteria (e.g.,
symptoms, age, gender, prior tests), the expertise of the per-
son conducting the test.
Example: How up to date is this review?
The review authors searched for and used studies
published from January 1980 to July 2015.
Example: Who do the results of this review apply
to?
The results may not be representative of all chil-
dren with sore throat being tested in the community.
Studies included in the review were carried out in 25
countries with almost half conducted in the United
States. Tests produced by many different manufac-
tures were assessed. The average age of children
was 7 years. Overall, an average of 29% of children
was found to have a bacterial throat infection with
this number ranging from 10% to 67% across studies.
There was some suggestion that studies in the review
included more severely ill children.
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This section provides the conclusions of the review. Start
with a brief summary statement regarding whether the re-
sults of the review suggest the index test has the potential
to be used to detect the target condition. If the evidence
is not sufficient to make a recommendation, this should
be stated here. For example, ‘‘It is unclear whether [index
test] can detect [target condition].’’
We suggest next including details on the incidence of
false positive and false negative test results and the conse-
















an‘‘Based on the results of this review, the chance of
wrongly diagnosing someone with [target condition]
when they do not actually have it appears [comment
on frequency, e.g., high, low] (XX% of those whose








Example: What are the implications of this review?
The studies in this review suggest that rapid tests can
tect the most common cause of bacterial infections
rep A) in children with sore throats, leading to early
d appropriate treatment with antibiotics. Both types
rapid tests studied in the review had similar accuracy.
e risk of missing a diagnosis of bacterial infection
th rapid tests is low (6% of those whose rapid tests
gests they do not have a bacterial infection) suggest-
that only a small number of childrenwith a bacterial
ection will not receive antibiotics. The risk of
ongly diagnosing a child as having a bacterial infec-
n is slightly higher (11% of those whose rapid test
gests they have a bacterial infection). Thismay result
some of these children receiving unnecessary antibi-
cs. The number of children receiving unnecessary an-
iotics after a rapid test is still likely to be lower than
number of children who would receive unnecessary
tibiotics if the test is not used.condition]) [comment on consequences]. The chance
of missing a diagnosis of [target condition] is
[comment on relative frequency, e.g., lower, higher]
(xx% of those whose [index test] results suggest they
do not have [target condition] when they actually
have it), [comment on consequences]. These findings
should be considered when deciding whether or not
to use the [index test] to test for [target condition].’’Details of variation in test accuracy estimates in partic-
ular subgroups, for example, different patient groups,
different test thresholds, different versions of the test, can
also be highlighted in this section.
2.9. How up to date is this review?
State when the review authors searched for the included
studies, for instance, by saying
‘‘The review authors searched for and used studies pub-
lished up to [date].’’3. Discussion
We have introduced a template and guidance on how to
write a PLS for a DTA review. Although the guidance was
primarily developed for Cochrane review authors, we
believe that it is equally relevant to other types of DTA re-
view. As far as we are aware, this is the first such guidance
available for DTA reviews. We hope that this will help au-
thors of DTA reviews to communicate the results of their
review in a more accessible way, leading to improved im-
plementation of results from these reviews. Although
PLSs primarily target a lay audience, given the complexity
of the metrics involved in the evaluation of diagnostic ac-
curacy, we think that the potential audience for a DTA
PLS is likely to be much broader than for reviews of inter-
ventions and include other end users such as health profes-
sionals, journalists, and commissioners. We involved all1. How to transform sensitivity, specificity, and prevalence to
l frequencies
Disease present Disease absent Total
tive
TP 5 x  sens FP 5 y  (y  spec) TP þ FP
tive
FN 5 x 
(x  sens)
TN 5 y  spec FN þ TN
x 5 1000  p y 5 1000 
(1000  p)
1000
mple: Prevalence of disease 5 30% (P 5 0.3), sensi-
85.6% (sens5 0.856), specificity 5 95.4% (spec5 0.954).
Table 2. Worked example showing how to transform sensitivity, specificity, and prevalence to natural frequencies
Disease present Disease absent Total
Test positive 300  0.856 5 257 700  (700  0.954) 5 32 TP þ FP 5 289
Test negative 300(300  0.856) 5 43 700  0.954 5 668 FN þ TN 5 711
1000  0.3 5 300 1000  300 5 700 1000
119P. Whiting et al. / Journal of Clinical Epidemiology 103 (2018) 112e119these groups in the development of the guidance to ensure
that the final template and guidance would be relevant for
them.
Summarizing results in plain language is challenging. To
be able to write a PLS, reviewers have to really understand
the results of their review. Our proposed PLS template en-
courages reviewers to consider the key messages from their
review, what the potential limitations of their review are,
and who results are applicable to. The exercise of writing
the PLS can also feedback into how the main results section
of the review is structured and can also help inform what
information to present in the scientific abstract. Once a
draft PLS has been produced, it can be helpful to ask a
lay member to comment on this. Ideally the review team
will include a lay member who will have some understand-
ing of the review topic and can contribute to developing the
PLS. They could be asked to comment on the draft PLS or
may be able to help in producing the PLS. An alternative
would be to share the PLS with an independent lay person
who could comment on their understanding and agreement
with the key messages of the review.
To conclude, PLS will enable users to better understand
the results and conclusions of DTA reviews. This will in-
crease the accessibility of these reviews for various audi-
ences. This article provides guidance to review authors on
how to write these summaries.Acknowledgments
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